Liquidia (LQDA) Goodwill & Intangibles (2020 - 2026)
Liquidia's (LQDA) quarterly Goodwill & Intangibles came in at $6.8 million in Q1 2026, down 28.7% year-on-year from $9.5 million in Q1 2025, and down 28.7% quarter-over-quarter from $9.5 million in Q4 2025.
Liquidia (LQDA) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
Liquidia's Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $6.8 million for Q1 2026.
- On a quarterly basis, Goodwill & Intangibles fell 28.7% year-over-year to $6.8 million in Q1 2026; TTM through Mar 2026 was $6.8 million, a 28.7% decrease from a year earlier, with the FY2025 full-year figure at $9.5 million, up 34.91% from the prior year.
- Goodwill & Intangibles retreated to $6.8 million in Q1 2026 per LQDA's latest filing, from $9.5 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $9.5 million in Q4 2022 and bottomed at $6.8 million in Q1 2026.
- The 5-year median for Goodwill & Intangibles is $8.1 million (2022), against an average of $8.4 million.
- Across the five-year window, Goodwill & Intangibles soared 34.91% in 2025 and declined 28.7% in 2026, its largest moves.
- Year by year, Goodwill & Intangibles stood at $9.5 million in 2022, then retreated by 23.0% to $7.3 million in 2023, then fell by 3.74% to $7.1 million in 2024, then jumped by 34.91% to $9.5 million in 2025, then retreated by 28.7% to $6.8 million in 2026.
- Per Business Quant, the three latest LQDA Goodwill & Intangibles figures stand at $6.8 million (Q1 2026), $9.5 million (Q4 2025), and $6.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.15 Bn | 20.99 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn |
| 10 | Liquidia | 7.65 Bn | 7.43 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.79 Mn |
| Dec 31, 2025 | 9.52 Mn |
| Sep 30, 2025 | 6.89 Mn |
| Jun 30, 2025 | 9.52 Mn |
| Mar 31, 2025 | 9.52 Mn |
| Dec 31, 2024 | 7.06 Mn |
| Sep 30, 2024 | 7.12 Mn |
| Jun 30, 2024 | 9.52 Mn |
| Mar 31, 2024 | 9.52 Mn |
| Dec 31, 2023 | 7.33 Mn |
| Sep 30, 2023 | 9.52 Mn |
| Jun 30, 2023 | 7.46 Mn |
| Mar 31, 2023 | 9.52 Mn |
| Dec 31, 2022 | 9.52 Mn |
| Sep 30, 2022 | 7.72 Mn |
| Jun 30, 2022 | 7.94 Mn |
| Mar 31, 2022 | 8.13 Mn |
| Dec 31, 2021 | 8.29 Mn |
| Sep 30, 2021 | 8.42 Mn |
| Jun 30, 2021 | 8.76 Mn |